Abbott Sues Mylan over AIDS Drug
March 17, 2009 by Alex
Filed under Patent Litigation
Abbott Laboratories has accused Mylan Inc. of infringing on two patents for Kaletra, a drug used for AIDS. The patents are due to expire in 2021, but Abott contends that Mylan plans to sell generic copies of Kaletra before that time, reports the Chicago Tribune.
Abott filed the lawsuit after Mylan announced that is Matrix Laboratories, based in India, had received a USFDA approval for the tablets under the president’s Emergency Plan for AIDS relief. Abott says that they company will be “irreparably harmed” if the generic versions of Kaletra aren’t blocked.
